Invesco’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Invesco’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-42,461	Closed	-$5K	–	3930
2018 Q4	$5K	Buy	+42,461	New	+$27.9K	﹤0.01%	3796
2017 Q1	–	Sell	-170,299	Closed	-$1.04M	–	3788
2016 Q4	$1.04M	Buy	+170,299	New	+$890K	﹤0.01%	2971
2016 Q3	–	Sell	-1,671,246	Closed	-$6.35M	–	3703
2016 Q2	$6.35M	Sell	1,671,246 -457,555	-21%	-$1.55M	﹤0.01%	1745
2016 Q1	$5.88M	Hold	2,128,801	–	–	﹤0.01%	1761
2015 Q4	$12.1M	Buy	2,128,801 +14,958	+0.7%	+$91.2K	﹤0.01%	1393
2015 Q3	$11.2M	Sell	2,113,843 -328,021	-13%	-$2.54M	﹤0.01%	1410
2015 Q2	$20.3M	Buy	2,441,864 +461,877	+23%	+$2.24M	0.01%	1208
2015 Q1	$9.15M	Buy	+1,979,987	New	+$6.44M	﹤0.01%	1591

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Invesco's SGYP Position: Q1 2019 in Review

Invesco sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 42,461 shares — an estimated $5K sold.

Invesco first reported a position in SGYP in Q1 2015 and held it in 8 quarters. The position peaked at $20.3M in Q2 2015. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Invesco reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Invesco sold 42,461 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $5K.
Invesco first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and held it in 8 quarters.
Invesco's Synergy Pharmaceuticals, Inc Common Stock position peaked at $20.3M in Q2 2015.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.